NALCKA’s U.S. trademark is owned by SENMIAO INC., an American enterprise based in Sheridan, Wyoming. Manufactured by Dovita Nutrition Health LLC, its U.S. factory—located at 5087 Walnut Grove Ave., Ste. A-1, San Gabriel, CA 91776—boasts Class 100,000 GMP clean workshops and strictly adheres to U.S. FDA standards and international GMP guidelines.
The factory’s joint laboratory, UltraSpec Lab (a high-tech facility registered in British Columbia, Canada), focuses on pharmaceutical formulation development through the integration of AI and biochemical technology. The UltraSpec team has developed a series of supramolecular drug matrices and nanodrug delivery systems, with research published in world-renowned journals such as Nature, Materials Today, and Biomaterials Science. It also maintains in-depth cooperation with Mitacs on biomedical diagnostic projects, achieving remarkable breakthroughs in research and product development.
Backed by a diverse, experienced R&D team—including experts from the University of Victoria, Delft University of Technology, the University of Cambridge, and Queen’s University—all NALCKA products are FDA-compliant, SGS-testable, and available on Amazon U.S. and selected local U.S. retailers.